Gene: ABHD17B
Official Full Name: abhydrolase domain containing 17B, depalmitoylaseprovided by HGNC
Gene Summary: Enables palmitoyl-(protein) hydrolase activity. Involved in protein depalmitoylation. Located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23037 | ABHD17B Knockout cell line (HeLa) | Human | ABHD17B | 1:3~1:6 | Negative | Online Inquiry |
KO23038 | ABHD17B Knockout cell line (HCT 116) | Human | ABHD17B | 1:2~1:4 | Negative | Online Inquiry |
KO23039 | ABHD17B Knockout cell line (HEK293) | Human | ABHD17B | 1:3~1:6 | Negative | Online Inquiry |
KO23040 | ABHD17B Knockout cell line (A549) | Human | ABHD17B | 1:3~1:4 | Negative | Online Inquiry |
ABHD17B Gene Knockout Cell Lines are precision-engineered cellular models crucial for studying the biological functions of the ABHD17B gene, a member of the serine hydrolase family implicated in various physiological processes, including lipid metabolism and neurotransmission. These knockout cell lines are generated using CRISPR-Cas9 technology, which facilitates the precise deletion of the ABHD17B gene, allowing researchers to investigate its role in cellular pathways and disease mechanisms.
The key functions of ABHD17B involve the hydrolysis of fatty acid amides and other lipid mediators, making these cell lines pivotal for studies focusing on lipid signaling and its ramifications in metabolic disorders or neurodegenerative diseases. By employing these knockout models, scientists can elucidate the specific contributions of ABHD17B to cellular behavior, providing profound insights into its potential as a therapeutic target.
In terms of scientific importance, these cell lines are vital for advancing research in pharmacology and toxicology, allowing for the assessment of drug candidates and their interactions with lipid metabolism pathways. Clinically, an understanding of the ABHD17B gene’s role could pave the way for innovative treatments targeting conditions such as obesity, anxiety, and pain modulation.
Compared to traditional gene silencing methods, our ABHD17B Gene Knockout Cell Lines offer several advantages, including durability, specificity, and reproducibility. These models eliminate off-target effects often associated with RNA interference, enabling more reliable results. Researchers will appreciate the ease of use and immediate applicability in high-throughput screening assays and mechanistic studies.
For scientists and clinicians seeking to deepen their understanding of lipid-related pathophysiology, our ABHD17B Gene Knockout Cell Lines stand as a valuable resource, facilitating significant advancements in both fundamental and translational research. Our commitment to quality and innovation in biological products ensures that you are accessing cell lines that meet the highest standards of scientific rigor, empowering your research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.